Jan 02, 2018 13:01 pm UTC| Business
--- Increases Core Net Leasehold Position and Net Drilling Inventory By 13% and 17%, Respectively --- --- Strong Well Results Ahead of Type Curve to Drive Early 2018 Production --- HOUSTON, Jan. 02,...
PositiveID Corporation Discusses 2017 Accomplishments in New Interview with CEOLIVE.TV
Jan 02, 2018 13:01 pm UTC| Business
DELRAY BEACH, Fla., Jan. 02, 2018 -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and CEO, William J. Caragol,...
Jan 02, 2018 13:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Jan. 02, 2018 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that it entered an amended agreement providing ApolloBio Corporation (NEEQ:430187) with the exclusive right to develop...
Selecta Biosciences Announces CEO’s Intent to Retire and Transition Plan
Jan 02, 2018 13:01 pm UTC| Business
Dr. Werner Cautreels Plans Retirement at the End of 2018Dr. Omid Farokhzad Appointed Chairman of the Board WATERTOWN, Mass., Jan. 02, 2018 -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical...
Biotricity Announces Expansion of Bioflux Sales Force and Pilot Sites
Jan 02, 2018 13:01 pm UTC| Business
REDWOOD CITY, Calif., Jan. 02, 2018 -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today...
Jan 02, 2018 13:01 pm UTC| Business
SUWANEE, GA, Jan. 02, 2018 -- SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the U.S. Food and Drug Administration (FDA) has issued its decision on the de novo submission for the dermaPACE® System. Their...
BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer
Jan 02, 2018 13:01 pm UTC| Business
CHICAGO, Jan. 02, 2018 -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla as its Chief Science Officer....